Literature DB >> 11673417

A 12-amino-acid segment, present in type s2 but not type s1 Helicobacter pylori VacA proteins, abolishes cytotoxin activity and alters membrane channel formation.

M S McClain1, P Cao, H Iwamoto, A D Vinion-Dubiel, G Szabo, Z Shao, T L Cover.   

Abstract

Helicobacter pylori, a gram-negative bacterium associated with gastritis, peptic ulceration, and gastric adenocarcinoma in humans, secretes a protein toxin, VacA, that causes vacuolar degeneration of epithelial cells. Several different families of H. pylori vacA alleles can be distinguished based on sequence diversity in the "middle" region (i.e., m1 and m2) and in the 5' end of the gene (i.e., s1 and s2). Type s2 VacA toxins contain a 12-amino-acid amino-terminal hydrophilic segment, which is absent from type s1 toxins. To examine the functional properties of VacA toxins containing this 12-amino-acid segment, we analyzed a wild-type s1/m1 VacA and a chimeric s2/m1 VacA protein. Purified s1/m1 VacA from H. pylori strain 60190 induced vacuolation in HeLa and Vero cells, whereas the chimeric s2/m1 toxin (in which the s1 sequence of VacA from strain 60190 was replaced with the s2 sequence from strain Tx30a) lacked detectable cytotoxic activity. Type s1/m1 VacA from strain 60190 formed membrane channels in a planar lipid bilayer assay at a significantly higher rate than did s2/m1 VacA. However, membrane channels formed by type s1 VacA and type s2 VacA proteins exhibited similar anion selectivities (permeability ratio, P(Cl)/P(Na) = 5). When an equimolar mixture of the chimeric s2/m1 toxin and the wild-type s1/m1 toxin was added to HeLa cells, the chimeric toxin completely inhibited the activity of the s1/m1 toxin. Thus, the s2/m1 toxin exhibited a dominant-negative phenotype similar to that of a previously described mutant toxin, VacA-(Delta6-27). Immunoprecipitation experiments indicated that both s2/m1 VacA and VacA-(Delta6-27) could physically interact with a c-myc epitope-tagged s1/m1 VacA, which suggests that the dominant-negative phenotype results from the formation of heterooligomeric VacA complexes with defective functional activity. Despite detectable differences in the channel-forming activities and cytotoxic properties of type s1 and type s2 VacA proteins, the conservation of type s2 sequences in many H. pylori isolates suggests that type s2 VacA proteins retain an important biological activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673417      PMCID: PMC95478          DOI: 10.1128/JB.183.22.6499-6508.2001

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  62 in total

1.  Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax.

Authors:  B R Sellman; M Mourez; R J Collier
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

2.  Helicobacter pylori strain-specific genotypes and modulation of the gastric epithelial cell cycle.

Authors:  R M Peek; M J Blaser; D J Mays; M H Forsyth; T L Cover; S Y Song; U Krishna; J A Pietenpol
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

3.  Identification and analysis of a new vacA genotype variant of Helicobacter pylori in different patient groups in Germany.

Authors:  S Strobel; S Bereswill; P Balig; P Allgaier; H G Sonntag; M Kist
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

4.  Geographic distribution of vacA allelic types of Helicobacter pylori.

Authors:  L J Van Doorn; C Figueiredo; F Mégraud; S Pena; P Midolo; D M Queiroz; F Carneiro; B Vanderborght; M D Pegado; R Sanna; W De Boer; P M Schneeberger; P Correa; E K Ng; J Atherton; M J Blaser; W G Quint
Journal:  Gastroenterology       Date:  1999-04       Impact factor: 22.682

5.  vacA genotypes and genetic diversity in clinical isolates of Helicobacter pylori.

Authors:  S R Han; H J Schreiber; S Bhakdi; M Loos; M J Maeurer
Journal:  Clin Diagn Lab Immunol       Date:  1998-03

6.  Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease.

Authors:  P Ghiara; M Marchetti; M J Blaser; M K Tummuru; T L Cover; E D Segal; L S Tompkins; R Rappuoli
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Single and multiple strain colonization in patients with Helicobacter pylori-associated gastritis: detection by macrorestriction DNA analysis.

Authors:  A M Hirschl; M Richter; A Makristathis; P M Prückl; B Willinger; K Schütze; M L Rotter
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

8.  Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains.

Authors:  T L Cover; M K Tummuru; P Cao; S A Thompson; M J Blaser
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

9.  Long-term colonization with single and multiple strains of Helicobacter pylori assessed by DNA fingerprinting.

Authors:  N S Taylor; J G Fox; N S Akopyants; D E Berg; N Thompson; B Shames; L Yan; E Fontham; F Janney; F M Hunter
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

10.  Acid-induced dissociation of VacA, the Helicobacter pylori vacuolating cytotoxin, reveals its pattern of assembly.

Authors:  T L Cover; P I Hanson; J E Heuser
Journal:  J Cell Biol       Date:  1997-08-25       Impact factor: 10.539

View more
  52 in total

1.  Fluorescence resonance energy transfer microscopy of the Helicobacter pylori vacuolating cytotoxin within mammalian cells.

Authors:  David C Willhite; Dan Ye; Steven R Blanke
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

2.  Expression of Helicobacter pylori vacuolating toxin in Escherichia coli.

Authors:  Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

3.  Reconstitution of Helicobacter pylori VacA toxin from purified components.

Authors:  Christian González-Rivera; Kelly A Gangwer; Mark S McClain; Ilyas M Eli; Melissa G Chambers; Melanie D Ohi; D Borden Lacy; Timothy L Cover
Journal:  Biochemistry       Date:  2010-07-13       Impact factor: 3.162

4.  Mapping of a domain required for protein-protein interactions and inhibitory activity of a Helicobacter pylori dominant-negative VacA mutant protein.

Authors:  Victor J Torres; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

Review 5.  Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors:  Dacie R Bridge; D Scott Merrell
Journal:  Gut Microbes       Date:  2013-02-04

6.  Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants.

Authors:  Rhonda R Caston; Johanna C Sierra; Nora J Foegeding; Mandy D Truelock; Anne M Campbell; Arwen E Frick-Cheng; Diane Bimczok; Keith T Wilson; Mark S McClain; Timothy L Cover
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

7.  Resistance of primary murine CD4+ T cells to Helicobacter pylori vacuolating cytotoxin.

Authors:  Holly M Scott Algood; Victor J Torres; Derya Unutmaz; Timothy L Cover
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

8.  Regional variation among vacA alleles of Helicobacter pylori in China.

Authors:  Jingtong Wang; Leen-Jan van Doorn; Philip A Robinson; Xuhuai Ji; Dong Wang; Yu Wang; Lianying Ge; John L Telford; Jean E Crabtree
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Epidemiological link between gastric disease and polymorphisms in VacA and CagA.

Authors:  Sungil Jang; Kathleen R Jones; Cara H Olsen; Young Min Joo; Yun-Jung Yoo; In-Sik Chung; Jeong-Heon Cha; D Scott Merrell
Journal:  J Clin Microbiol       Date:  2009-12-02       Impact factor: 5.948

10.  Diversity of VacA intermediate region among Helicobacter pylori strains from several regions of the world.

Authors:  Christine Chung; Asalia Olivares; Eugenia Torres; Ozlem Yilmaz; Henry Cohen; Guillermo Perez-Perez
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.